作者: Guillaume Cartron , Herve Watier , Phillippe Colombat
DOI:
关键词:
摘要: The present invention relates to methods and compositions evaluate or assess the response of a subject particular therapeutic treatment. More particularly, provides determine subjects, adapt treatment protocol subjects treated with antibodies. is based on determination FCGR3A genotype subject. can be used for patients malignancies, particularly lymphoma, suited select best responders and/or adjust condition low responders.